Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

John Dundon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Jeevithan Elango | Dentistry | Best Researcher Award

Published on by Invention Awards

Prof. Jeevithan Elango | Dentistry | Best Researcher Award

Professor of UCAM, Spain

Dr. Jeevithan Elango is a distinguished Professor at the Department of Biomaterials Engineering, UCAM San Antonio Catholic University of Murcia, Spain 🇪🇸. With a Ph.D. in Food Science 🎓 from Shanghai Ocean University, he has made significant contributions to marine bio-pharmacology and biomaterials. His research focuses on Type-II collagen from shark cartilage and its impact on immunological tolerance and osteogenesis 🦈🔬. Dr. Elango has been recognized with several awards 🏆, including the International Young Scientist Award from the National Natural Science Foundation of China 🇨🇳. He is also an active member of various scientific committees and editorial boards 📚.

 

Education 📖

Dr. Jeevithan Elango holds a Ph.D. in Food Science (93.1% with Distinction) 🎓 from Shanghai Ocean University, China 🇨🇳, where he studied biochemical characterization of Type-II collagen from shark cartilage 🦈. He earned his M.Sc. in Biochemistry (74.52% with Distinction) 🧪 from Thanthai Hans Roever College, Bharathidasan University, India 🇮🇳, and a B.Sc. in Biochemistry (71.2%) 🧬 from the same institution. His foundational education includes an HSC (74.6%) 📚 and SSLC (82.8%) 📖 from Sengunthar Higher Secondary School in Trichy, Tamilnadu.

 

Professional Expereience🔬

Dr. Jeevithan Elango is currently a Professor at UCAM San Antonio Catholic University of Murcia, Spain 🇪🇸, and a Distinguished Adjunct Faculty at Saveetha University, India 🇮🇳. Previously, he served as an Associate Professor and Postdoctoral Researcher at Shanghai Ocean University, China 🇨🇳. His global research experience includes a tenure as an International Research Scholar in Australia 🇦🇺. He has also held Senior Research Fellow positions on various projects in India 🇮🇳. Dr. Elango’s expertise spans biomaterials, food science, and marine bio-pharmacology 🌊🔬.

 

Research Interest 🧫

Dr. Jeevithan Elango’s research interests are centered on biomaterials and marine bio-pharmacology 🌊🔬. He focuses on the biochemical characterization of Type-II collagen and collagenous polypeptides from shark cartilage 🦈, investigating their effects on immunological tolerance and osteogenesis 🦴. His work extends to the development of biodegradable polymers, fish processing waste utilization, and the synthesis of collagen and gelatin films for biomedical applications 🧫. Dr. Elango is dedicated to advancing sustainable and innovative solutions in the fields of health sciences and biomaterials engineering 🌱🧬.

Award and Honor 🎓

Dr. Jeevithan Elango has received numerous awards and honors for his contributions to science and research 🏆. He was awarded the Academic Winner Award by the Royal Academy of Medicine and Surgery of Murcia 🇪🇸 and the “Endeavour Scholarships and Fellowships” by the Australian Government 🇦🇺. He also received the “International Young Scientist” Award from the National Natural Science Foundation of China 🇨🇳 and was recognized as the Best Oral Presenter at an international conference in India 🇮🇳. Additionally, Dr. Elango has been honored with the Shanghai State Government Doctoral Scholarship 🎓.

Research skill 🧪

Dr. Jeevithan Elango possesses a diverse skill set in research and biomaterials engineering 🌊🔬. He specializes in the biochemical characterization of marine-derived Type-II collagen 🦈 and its applications in immunology and osteogenesis 🦴. His expertise includes developing biodegradable polymers, synthesizing collagen and gelatin films, and utilizing fish processing waste for biomedical uses 🧫. Dr. Elango is proficient in molecular biology techniques, data analysis, and project management 🧪📊. His innovative approach and interdisciplinary knowledge contribute to advancements in health sciences and sustainable biomaterials engineering 🌱🧬.

Achievements 🏆 

  • Academic Winner Award in the National Prize Contest 2022 by the Royal Academy of Medicine and Surgery of Murcia 🇪🇸
  • Endeavour Scholarships and Fellowships 2016 funded by the Australian Government for an internship at St. Vincent’s Institute of Medical Research 🇦🇺
  • International Young Scientist Award from the National Natural Science Foundation of China 🇨🇳
  • International Young Scientist Award from the National Natural Science Foundation of China 🇨🇳
  • Best Oral Presenter at the International Conference on Emerging Issues in Quality and Safety of Fish and Shellfish (EIQASFISH 2016) 🇮🇳
  • Shanghai State Government Doctoral Scholarship recipient 🎓
  • AMBASSADOR 2022 for World Osteoarthritis Day, Brussels, Belgium 🌍
  • Reviewers Award of the International Journal of Molecular Science in 2019 📚

Projects 🏆

  • Development of Database for Indian Seafood Safety and Traceability based on AFLP markers (SERB-MFPI funded) 🐟📈
  • Messenger RNA-Based Assay for RT-PCR Detection of viable Salmonella and Vibrio cholerae in fresh and processed finfish and shellfish (DBT funded) 🧫🔬
  • Collagen and Gelatin Film Formation from Fish Processing Wastes and their functional properties (DBT funded) 🐠🧪
  • Contraceptive Efficacy of Fractionation of Andrographis paniculata stem, leaves, and root (UGC Major Research Project) 🌿🔬

 

Publications📄

 

📄 Novel bioactive and biocompatible alumina-wollastonite porous constructs mimicking physical properties of human cortical bone

  • Authors: González-Sánchez, M., Zamora-Ledezma, C., Elango, J., Morales-Flórez, V.
  • Journal: Journal of the European Ceramic Society, 2024, 44(7), pp. 4699–4708
  • Citations: 0

🌊 Purification and Characterization of a Novel Fibrinolytic Enzyme from Marine Bacterium Bacillus sp. S-3685 Isolated from the South China Sea

  • Authors: Ma, Z., Elango, J., Hao, J., Wu, W.
  • Journal: Marine Drugs, 2024, 22(6), 267
  • Citations: 0

🦑 Stem-Cell-Regenerative and Protective Effects of Squid (Symplectoteuthis oualaniensis) Skin Collagen Peptides against H2O2-Induced Fibroblast Injury

  • Authors: Wei, M., Jeevithan, L., Li, N., Wu, W., Elango, J.
  • Journal: Marine Drugs, 2024, 22(6), 255
  • Citations: 0

🦴 Fabrication of novel strontium-coated bioactive ceramic-glass (C2S(2P6)C2S) 3D-porous scaffold for the proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells

  • Authors: Elango, J., Salazar, K., Velasquez, P., Granero Marín, J.M., Mate Sanchez de Val, J.E.
  • Journal: Ceramics International, 2024, 50(10), pp. 16998–17010
  • Citations: 1

🔬 3D printed bioactive calcium silicate ceramics as antibacterial scaffolds for hard tissue engineering

  • Authors: El Hayek, J., Belaid, H., de Saint Cyr, L.C., Soussan, L., Salameh, C., Elango, J.
  • Journal: Materials Advances, 2024, 5(8), pp. 3228–3246
  • Citations: 1

🦴 Enhancing bone tissue regeneration with rGO-coated Si-Ca-P bioceramic scaffold | Potenciación de la regeneración ósea a través de una biocerámica de Si-Ca-P recubierta con grafeno reducido

  • Authors: Mazón, P., Elango, J., Val, J.E.M.-S.D., De Aza, P.N.
  • Journal: Boletin de la Sociedad Espanola de Ceramica y Vidrio, 2024, 63(1), pp. 59–71
  • Citations: 1

🔍 Natural vs Synthetic Polymers: How Do They Communicate with Cells for Skin Regeneration—A Review

  • Authors: Elango, J., Zamora-Ledezma, C., Maté-Sánchez de Val, J.E.
  • Journal: Journal of Composites Science, 2023, 7(9), 385
  • Citations: 1

🦑 Collagen from Iris squid grafted with polyethylene glycol and collagen peptides promote the proliferation of fibroblast through PI3K/AKT and Ras/RAF/MAPK signaling pathways

  • Authors: Hou, C., Lei, Y., Li, N., Wu, W., Elango, J.
  • Journal: International Journal of Biological Macromolecules, 2023, 247, 125772
  • Citations: 2

💊 Protein Adsorption, Calcium-Binding Ability, and Biocompatibility of Silver Nanoparticle-Loaded Polyvinyl Alcohol (PVA) Hydrogels Using Bone Marrow-Derived Mesenchymal Stem Cells

  • Authors: Elango, J., Zamora-Ledezma, C., Alexis, F., Wu, W., Maté-Sánchez de Val, J.E.
  • Journal: Pharmaceutics, 2023, 15(7), 1843
  • Citations: 1

🩹 Fabrication, Physical–Chemical and Biological Characterization of Retinol-Loaded Poly(vinyl Alcohol) Electrospun Fiber Mats for Wound Healing Applications

  • Authors: Zamora-Ledezma, C., Hernández, A.B., López-González, I., Mowbray, D.J., Meseguer-Olmo, L., Elango, J.
  • Journal: Polymers, 2023, 15(12), 2705
  • Citations: 1

John T McDevitt | Dentistry | Best Researcher Award

Published on by Invention Awards

Prof. John T McDevitt | Dentistry | Best Researcher Award

 Professor of New York University, United States

🌟 Professor John T. McDevitt is a distinguished figure in biomaterials and ‘smart diagnostic‘ technologies at NYU College of Dentistry. As a visionary leader and founder of multiple diagnostic firms like OraLiva, he pioneers innovations for early disease detection. His extensive research, comprising 219+ publications and 145+ patents, reflects his profound impact on healthcare. Recognized with accolades such as the AACC Wallace H. Coulter Lectureship Award and the Presidential Young Investigator Award, Dr. McDevitt’s work integrates AI-linked sensors for diseases like oral cancer and COVID-19, securing over $47M in NIH funding. His contributions epitomize excellence in translating bioscience into transformative clinical solutions. 🏥

Professional Profile:

Education🎓

🎓 Professor John T. McDevitt pursued his academic journey with zeal, earning a B.S. in Chemistry/Sensors Devices from California Polytechnic State University in 1982. He continued his quest for knowledge at Stanford University, where he obtained his Ph.D. in Physical/Materials Chemistry in 1987. Following this, he conducted postdoctoral research in Analytical/Materials Chemistry at the University of North Carolina from 1987 to 1989. These formative years laid the foundation for his illustrious career in biomaterials and bioengineering, shaping his expertise in developing groundbreaking ‘smart diagnostic‘ technologies that advance healthcare. 📚

Professional Experience 📚

🌟 Professor John T. McDevitt brings over three decades of distinguished professional experience to his role. Currently serving as a Full Professor in the Division of Biomaterials at New York University College of Dentistry, he is also affiliated with the Bioengineering Institute and the Department of Chemical and Biomolecular Engineering at the Tandon School of Engineering. Previously, he held notable positions such as Chair of the Department of Biomaterials at NYU and the Brown-Weiss Professor of Bioengineering and Chemistry at Rice University. His leadership extends to directing multiple research consortia and clinical studies, driving innovations in smart diagnostic technologies for early disease detection and management. 🏆

Research Interest 🔍

🔬 Professor John T. McDevitt is deeply engaged in pioneering research at the intersection of biomaterials, bioengineering, and chemical engineering. His research endeavors focus on developing advanced ‘smart diagnostic‘ technologies aimed at revolutionizing healthcare delivery. His primary interests lie in creating miniaturized sensor ensembles and lab-on-a-chip systems for rapid, accurate disease diagnosis at the point of care. With a strong emphasis on integrating artificial intelligence with biomedical devices, his work spans critical areas such as oral cancer detection, COVID-19 severity assessment, and cardiac disease monitoring. Professor McDevitt’s innovative approach aims to enhance early detection capabilities, thereby improving patient outcomes and healthcare efficiency. 🌐

Award and Honor🏆

🏆 Professor John T. McDevitt has garnered prestigious awards and honors for his pioneering contributions to biomedical engineering and diagnostics. His groundbreaking work in developing ‘smart diagnostic‘ technologies has earned him recognition, including the 2016 AACC Wallace H. Coulter Lectureship Award and the Popular Science Best of What’s New Award in the Medical Device Category. He has also been honored with the Presidential Young Investigator Award and the Grace Fellowship, Stanford University. These accolades underscore his leadership in translating cutting-edge research into impactful clinical applications, further solidifying his reputation as a trailblazer in the field of bio-nanotechnology. 🌟

Research Skills🌟

🔬 Professor John T. McDevitt is renowned for his exceptional research skills in bio-nanotechnology and biomedical engineering. His expertise lies in developing advanced diagnostic technologies, including ‘smart diagnostic‘ devices and lab-on-a-chip systems. With over 219 peer-reviewed publications and more than 145 patents/patent applications to his name, he has made significant contributions to the field. Prof. McDevitt’s research focuses on integrating nanotechnology with clinical diagnostics, leveraging AI and mini-sensor ensembles for point-of-care testing. His innovative approach has revolutionized disease detection and monitoring, addressing critical healthcare challenges through interdisciplinary collaboration and cutting-edge scientific inquiry. 🌐

Achievements🏆

  • 🔬 Developed pioneering ‘smart diagnostic’ technologies.🏆 Received the 2016 AACC Wallace H. Coulter Lectureship Award.

    🌟 Honored with the Kathleen C. Kinnally Outstanding Scientific Achievement Award.

    🎖️ Recognized by Popular Science with the Best of What’s New Award in Medical Devices.

    🏅 Received the Presidential Young Investigator Award.

    📈 Elevated the field with over 219 peer-reviewed publications and 145 patents.

    💡 Founded multiple diagnostic companies, including OraLiva, advancing clinical diagnostics.

    💰 Raised over $47M in federal and foundation funding for research.

    🌐 Contributed to global health initiatives like HIV monitoring in Africa.

    🎓 Distinguished career spanning leadership roles at Rice University and NYU, shaping the future of bioengineering and biomaterials.

Projects💧🔬

  • 🔬 Point-of-Care Oncology Tool: Developed the first point-of-care oncology tool for precision medicine to monitor malignant transitions and recurrence in patients with oral epithelial dysplasia and prior oral cavity cancers.🧪 Lab-on-a-Chip System for Saliva-Based Diagnostics: Created a groundbreaking lab-on-a-chip system for saliva-based diagnostics aimed at cardiac disease, integrating 17 protein biomarkers for effective diagnosis.

    🦷 Monitoring Oral Cancer Patients: Led a project using novel lab-on-a-chip ensembles to monitor oral cancer patients, identifying cellular markers crucial for early detection and treatment.

    🔍 Texas Cancer Diagnostics Pipeline Consortium: Spearheaded multiple initiatives under this consortium focusing on oral, ovarian, and prostate cancers, employing advanced bio-nanochips to enhance diagnostic accuracy.

    🚔 Saliva-Based Drug Test at Point of Arrest: Designed bio-nanochips for saliva-based drug tests used at the point of arrest, aiding in the detection of drugs and metabolites efficiently.

Publications 📚

📚 Current developments in salivary diagnostics

  • Authors: CS Miller, JD Foley, AL Bailey, CL Campell, RL Humphries, …
  • Journal: Biomarkers in Medicine
  • Volume: 4
  • Issue: 1
  • Pages: 171-189
  • Citations: 509
  • Year: 2010

🔬 Aptamer-based sensor arrays for the detection and quantitation of proteins

  • Authors: R Kirby, EJ Cho, B Gehrke, T Bayer, YS Park, DP Neikirk, JT McDevitt, …
  • Journal: Analytical Chemistry
  • Volume: 76
  • Issue: 14
  • Pages: 4066-4075
  • Citations: 402
  • Year: 2004

🔍 Application of microchip assay system for the measurement of C-reactive protein in human saliva

  • Authors: N Christodoulides, S Mohanty, CS Miller, MC Langub, PN Floriano, …
  • Journal: Lab on a Chip
  • Volume: 5
  • Issue: 3
  • Pages: 261-269
  • Citations: 316
  • Year: 2005

👅 Solution-based analysis of multiple analytes by a sensor array: toward the development of an “electronic tongue”

  • Authors: JJ Lavigne, S Savoy, MB Clevenger, JE Ritchie, B McDoniel, SJ Yoo, …
  • Journal: Journal of the American Chemical Society
  • Volume: 120
  • Issue: 25
  • Pages: 6429-6430
  • Citations: 295
  • Year: 1998

🔬 Detection system based on an analyte reactive particle

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,602,702
  • Citations: 289
  • Year: 2003

🌟 Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels

  • Authors: JV Jokerst, A Raamanathan, N Christodoulides, PN Floriano, AA Pollard, …
  • Journal: Biosensors and Bioelectronics
  • Volume: 24
  • Issue: 12
  • Pages: 3622-3629
  • Citations: 283
  • Year: 2009

🩺 A microchip CD4 counting method for HIV monitoring in resource-poor settings

  • Authors: WR Rodriguez, N Christodoulides, PN Floriano, S Graham, S Mohanty, …
  • Journal: PLoS Medicine
  • Volume: 2
  • Issue: 7
  • Pages: e182
  • Citations: 272
  • Year: 2005

🔬 Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities

  • Authors: A Goodey, JJ Lavigne, SM Savoy, MD Rodriguez, T Curey, A Tsao, …
  • Journal: Journal of the American Chemical Society
  • Volume: 123
  • Issue: 11
  • Pages: 2559-2570
  • Citations: 260
  • Year: 2001

💡 Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study

  • Authors: PN Floriano, N Christodoulides, CS Miller, JL Ebersole, J Spertus, …
  • Journal: Clinical Chemistry
  • Volume: 55
  • Issue: 8
  • Pages: 1530-1538
  • Citations: 256
  • Year: 2009

🧬 Differential receptors create patterns diagnostic for ATP and GTP

  • Authors: SC McCleskey, MJ Griffin, SE Schneider, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 125
  • Issue: 5
  • Pages: 1114-1115
  • Citations: 245
  • Year: 2003

🔬 A microchip-based multianalyte assay system for the assessment of cardiac risk

  • Authors: N Christodoulides, M Tran, PN Floriano, M Rodriguez, A Goodey, M Ali, …
  • Journal: Analytical Chemistry
  • Volume: 74
  • Issue: 13
  • Pages: 3030-3036
  • Citations: 229
  • Year: 2002

🎨 Self-assembly of conjugated polymers at the air/water interface. Structure and properties of Langmuir and Langmuir− Blodgett films of amphiphilic regioregular polythiophenes

  • Authors: N Reitzel, DR Greve, K Kjaer, PB Howes, M Jayaraman, S Savoy, …
  • Journal: Journal of the American Chemical Society
  • Volume: 122
  • Issue: 24
  • Pages: 5788-5800
  • Citations: 223
  • Year: 2000

🛠️ Method and apparatus for the delivery of samples to a chemical sensor array

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,713,298
  • Citations: 212
  • Year: 2004

🔧 Systems and methods including self-contained cartridges with detection systems and fluid delivery systems

  • Authors: JT McDevitt, K Ballard, NJ Christodoulides, PN Floriano, GW Simmons
  • Publication: US Patent App. 11/993,705
  • Citations: 203
  • Year: 2010

🧪 Boronic acid based peptidic receptors for pattern-based saccharide sensing in neutral aqueous media, an application in real-life samples

  • Authors: NY Edwards, TW Sager, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 129
  • Issue: 44
  • Pages: 13575-13583
  • Citations: 203
  • Year: 2007